Litcius/Paper detail

Rs-1884444 G/T variant in IL-23 receptor is likely to modify risk of bladder urothelial carcinoma by regulating IL-23/IL-17 inflammatory pathway

Mohammed S. El‐Gedamy, Zakaria El-Khayat, Hassan Abol‐Enein, Afaf Elsaid, Eslam M. El-Nahrery

2020Cytokine15 citationsDOI

Topics & Concepts

InflammationAlleleImmune systemMalignancyReceptorBiologyImmunologyCancer researchT cellMedicineInternal medicineOncologyGeneticsGeneIL-33, ST2, and ILC PathwaysBladder and Urothelial Cancer TreatmentsAsthma and respiratory diseases
Rs-1884444 G/T variant in IL-23 receptor is likely to modify risk of bladder urothelial carcinoma by regulating IL-23/IL-17 inflammatory pathway | Litcius